JAK drugs for Psoriatic Arthritis

2 tracked JAK drugs in the Psoriatic Arthritis race. The class explanation lives on the JAK page; the full indication pipeline across every mechanism is on the Psoriatic Arthritis page.

2 approved / phase 4

Head-to-head evidence: tofacitinib vs upadacitinib

The roster

← all JAK drugs